BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9679612)

  • 1. [Significance of multidrug resistance in the therapy of malignant tumors].
    Pitlik E; Holló Z
    Orv Hetil; 1996 Dec; 137(50):2783-90. PubMed ID: 9679612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of multidrug resistance in cancer chemotherapy.
    Nooter K; Stoter G
    Pathol Res Pract; 1996 Jul; 192(7):768-80. PubMed ID: 8880878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The causes of treatment ineffectiveness in acute myelogenous leukemia--the role of blast resistance to cytotoxic drugs].
    Machaczka M; Rucińska M; Jabłoński M; Skotnicki AB
    Przegl Lek; 1998; 55(7-8):407-13. PubMed ID: 10021886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of steroidal alkaloids on drug transport and multidrug resistance in human cancer cells.
    Lavie Y; Harel-Orbital T; Gaffield W; Liscovitch M
    Anticancer Res; 2001; 21(2A):1189-94. PubMed ID: 11396162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug resistance in pediatric malignancies.
    Chan HS; DeBoer G; Haddad G; Gallie BL; Ling V
    Hematol Oncol Clin North Am; 1995 Apr; 9(2):275-318. PubMed ID: 7642465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistance: clinical relevance in solid tumours and strategies for circumvention.
    Kaye SB
    Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S15-9. PubMed ID: 9801854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts.
    Klement G; Huang P; Mayer B; Green SK; Man S; Bohlen P; Hicklin D; Kerbel RS
    Clin Cancer Res; 2002 Jan; 8(1):221-32. PubMed ID: 11801563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multidrug resistance of malignant tumors].
    Bak M
    Orv Hetil; 1991 Oct; 132(40):2187-92. PubMed ID: 1682863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of mitomycin C and carboplatin pretreatment on multidrug resistance-associated P-glycoprotein expression and on subsequent suppression of tumor growth by doxorubicin and paclitaxel in human metastatic breast cancer xenografted nude mice.
    Ihnat MA; Nervi AM; Anthony SP; Kaltreider RC; Warren AJ; Pesce CA; Davis SA; Lariviere JP; Hamilton JW
    Oncol Res; 1999; 11(7):303-10. PubMed ID: 10757444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug resistance: molecular and clinical aspects.
    Dicato M; Duhem C; Pauly M; Ries F
    Cytokines Cell Mol Ther; 1997 Jun; 3(2):91-9. PubMed ID: 9287248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression.
    Burak Z; Moretti JL; Ersoy O; Sanli U; Kantar M; Tamgac F; Basdemir G
    J Nucl Med; 2003 Sep; 44(9):1394-401. PubMed ID: 12960182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial multidrug resistance mediated by a homologue of the human multidrug transporter P-glycoprotein.
    Konings WN; Poelarends GJ
    IUBMB Life; 2002; 53(4-5):213-8. PubMed ID: 12120998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and significance of P-gp/mdr1 mRNA, MRP and LRP in non-Hodgkin's lymphoma].
    Li L; Su LP; Ma L; Zhao J; Zhu L; Zhou YA
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):199-202. PubMed ID: 19615260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming multidrug resistance in cancer: clinical studies of p-glycoprotein inhibitors.
    Coley HM
    Methods Mol Biol; 2010; 596():341-58. PubMed ID: 19949931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multiple drug resistance: a problem in cancer chemotherapy].
    Lizano Soberón M; Barrera Rodríquez R
    Rev Invest Clin; 1993; 45(5):481-92. PubMed ID: 7907810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multidrug or pleiotropic resistance].
    Arvelo F; Merentes E; Cotte C
    Acta Cient Venez; 2000; 51(1):45-52. PubMed ID: 10974707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multidrug resistance and its reversal. General review of fundamental aspects].
    Robert J
    Ann Biol Clin (Paris); 1996; 54(1):3-8. PubMed ID: 8731788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of multidrug resistance-associated proteins in paediatric soft tissue sarcomas before and after chemotherapy.
    Citti A; Boldrini R; Inserra A; Alisi A; Pessolano R; Mastronuzzi A; Zin A; De Sio L; Rosolen A; Locatelli F; Fruci D
    Int J Oncol; 2012 Jul; 41(1):117-24. PubMed ID: 22504834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug resistance in cancer: its mechanism and its modulation.
    Pauwels EK; Erba P; Mariani G; Gomes CM
    Drug News Perspect; 2007; 20(6):371-7. PubMed ID: 17925891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound reverses multidrug resistance in human cancer cells by altering gene expression of ABC transporter proteins and Bax protein.
    Wu F; Shao ZY; Zhai BJ; Zhao CL; Shen DM
    Ultrasound Med Biol; 2011 Jan; 37(1):151-9. PubMed ID: 21084157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.